Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02933112 · ClinicalTrials.gov registry record · NA

Workflow Validation of an In-home Auto-titrating Mandibular Positioner

A NA study of Obstructive Sleep Apnea, sponsored by Zephyr Sleep Technologies.

Completed
Registry status
NA
Development phase
71
Enrollment target
1
Study location

NCT02933112: Completed NA study of Obstructive Sleep Apnea, sponsored by Zephyr Sleep Technologies.

NCT02933112 is a NA study of Obstructive Sleep Apnea that has completed, run by Zephyr Sleep Technologies. The registered enrollment target is 71 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02933112, a NA study of Obstructive Sleep Apnea, has completed, sponsored by Zephyr Sleep Technologies.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to test the workflow of an auto-titrating mandibular positioner in its intended setting. Participants with obstructive sleep apnea will use the device to determine their eligibility for oral appliance therapy and provide feedback on usability of the device.

Primary Outcome

Data for this outcome are largely directed at the study staff, not study participants. Data collected for this outcome include: time required to evaluate eligibility for device use, prepare device for use, and ease of scheduling of study visits

Conditions Studied

Interventions

  • DEVICE Auto-titrating mandibular positioner test

Study Locations (1)

Washington

  • Premier Sleep - Bellevue

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2016-10
Est. Completion 2018-10-11
Phase NA
Zephyr Sleep Technologies

4 total trials

What the finished NCT02933112 record still lists

NCT02933112 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (68% lower).

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Auto-titrating mandibular positioner test is the first listed.

NCT02933112 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02933112 about?

NCT02933112 is a clinical study titled "Workflow Validation of an In-home Auto-titrating Mandibular Positioner". The purpose of the study is to test the workflow of an auto-titrating mandibular positioner in its intended setting. Participants with obstructive sleep apnea will use the device to determine their eligibility for oral appliance therapy and provide feedback on usability of the device.

What is the current status of trial NCT02933112?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2016-10. Estimated completion is 2018-10-11.

What conditions does trial NCT02933112 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT02933112?

The interventions under investigation include: Auto-titrating mandibular positioner test (DEVICE).

Who is sponsoring clinical trial NCT02933112?

This trial is sponsored by Zephyr Sleep Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02933112 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02933112's enrollment target sits among peer trials

71 79th of 155 higher than 77 of 155 other Obstructive Sleep Apnea trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05452889 · 71 participants · Early Phase 1

    PET Image in PAH Patients

  • NCT05766943 · 71 participants · NA

    Reduction of Myopotential Interference With Smart Pass in S-ICD Patients

  • NCT06229678 · 71 participants · Early Phase 1

    Ketones, SGLT2, HFrEF

  • NCT06377566 · 71 participants · Phase 2

    A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02933112, the US trial registry maintained by the National Library of Medicine. NCT02933112 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.